Candel Therapeutics Inc (NAS:CADL) Stock News, Headlines & Updates
Candel Therapeutics Inc Stock News from GuruFocus
- 1
Jun 18, 2024
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Marketwired • 7:00am
Jun 11, 2024
Candel Therapeutics to Join Russell 3000® Index
Marketwired • 7:00am
May 30, 2024
FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
Marketwired • 7:00am
May 22, 2024
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
Marketwired • 7:00am
May 20, 2024
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
Marketwired • 7:00am
May 14, 2024
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Marketwired • 7:00am
Apr 25, 2024
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
Marketwired • 7:00am
Apr 11, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news